期刊文献+
共找到12篇文章
< 1 >
每页显示 20 50 100
Investigating the antibiofilm activity of Terebinthinae oleum 30C,200C,and 1M against urinary tract infections-causing Escherichia coli
1
作者 Sibin Ramabhadran Anandavally Murugan Muthum Perumal Vel amrita Ganesan 《Infectious Diseases Research》 2025年第3期16-22,共7页
Background:Urinary tract infections(UTIs),primarily caused by uropathogenic Escherichia coli(UPEC),are a significant global health concern.The complications arise from antibiotic resistance and biofilm formation,which... Background:Urinary tract infections(UTIs),primarily caused by uropathogenic Escherichia coli(UPEC),are a significant global health concern.The complications arise from antibiotic resistance and biofilm formation,which reduce the effectiveness of conventional treatments.This study aims to evaluate the antibiofilm activity of the homeopathic medicine Terebinthinae oleum in potencies 30C,200C,and 1M against UTI-causing E.coli,and to compare its effectiveness with the standard antibiotic Gentamycin.Methods:An in-vitro biofilm model was employed.E.coli biofilms were cultivated in microtiter plates and treated with Terebinthinae oleum(30C,200C,1M)and Gentamycin.Biofilm biomass was assessed through crystal violet staining,and optical density(OD)was measured using an ELISA microplate reader.Results:Among the tested potencies,Terebinthinae oleum 30C showed the most prominent inhibitory activity on E.coli biofilms.The inhibition percentage was compared with Gentamycin as a control.Terebinthinae oleum 30C demonstrated 41.88%inhibition of biofilm biomass,while Gentamycin exhibited up to 78.98%inhibition.Higher potencies of Terebinthinae oleum(200C and 1M)showed reduced activity(30.15%and 24.81%,respectively).Conclusion:Terebinthinae oleum,especially at 30C potency,exhibits measurable antibiofilm activity against E.coli,although less effective than Gentamycin.These findings support its use as a complementary therapy in managing biofilm-associated UTIs,justifying further clinical and immunological research. 展开更多
关键词 urinary tract infection Escherichia coli Terebinthinae oleum biofilm HOMOEOPATHY GENTAMYCIN crystal violet antibiofilm activity
暂未订购
使用阴道避孕环与口服避孕药后的子宫内炔雌醇与依托孕烯浓度比较 被引量:1
2
作者 Roumen F.J.M.E. Dieben T.O.M. 李跃萍 《世界核心医学期刊文摘(妇产科学分册)》 2006年第4期25-25,共1页
Objective: To compare uterine tissue concentrations of ethinyl estradiol (EE) and etonogestrel (ENG) after one cycle of use of a contraceptive vaginal ring (NuvaRing;NV Organon, Oss, The Netherlands) or a combined ora... Objective: To compare uterine tissue concentrations of ethinyl estradiol (EE) and etonogestrel (ENG) after one cycle of use of a contraceptive vaginal ring (NuvaRing;NV Organon, Oss, The Netherlands) or a combined oral contraceptive (COC). Design: Randomized, open-label, pharmacokinetic study. Setting: Obstetrics and gynecology unit. Patient(s): Eight premenopausal women about to undergo hysterectomy but otherwise healthy. Intervention(s): One cycle (17-21 days) of NuvaRing or COC treatment that ended with surgical hysterectomy. Main Outcome Measure(s): Tissue concentrations of EE and ENG in uterine tissue samples taken from the upper myometrium and mid-myometrium, the cervical region, and the endometrium. Result(s): In both groups, concentrations of EE and ENG were similar in uterine tissue taken from the upper myometrium and mid-myometrium and the cervical region. However, compared with the COC group, concentrations of both hormones were markedly lower in tissue samples from the endometrium of women who had been treated with NuvaRing. Conclusion(s): Vaginal administration of hormones with NuvaRing did not produce elevated uterine concentrations of EE and ENG, compared with an oral contraceptive. 展开更多
关键词 阴道避孕环 口服避孕药 炔雌醇 绝经前女性 肌层 药代动力学 颈区
暂未订购
中、美、欧、日药典体系架构的比较 被引量:1
3
作者 徐昕怡 刘贞 +6 位作者 陶乐然 宋皞昀 李丹 于文力 王冠男 李浩 杨昭鹏 《中国药品标准》 CAS 2024年第3期209-219,共11页
标准体系是指一定范围内的标准按其内在联系形成的科学的有机整体。药品标准体系的完善程度对药品安全的保障起到举足轻重的作用。药典是药品标准体系的核心。本文通过梳理《中国药典》、美国药典-国家处方集、欧洲药典、日本药典体系架... 标准体系是指一定范围内的标准按其内在联系形成的科学的有机整体。药品标准体系的完善程度对药品安全的保障起到举足轻重的作用。药典是药品标准体系的核心。本文通过梳理《中国药典》、美国药典-国家处方集、欧洲药典、日本药典体系架构,从总体架构、各论标准架构、凡例架构、通用技术要求架构和其他标准架构,以及各类型标准的执行方式等方面进行比较,旨在为《中国药典》标准体系的优化完善提供参考借鉴。 展开更多
关键词 药典 通用技术要求 架构 互操作性 比较
暂未订购
中、美、欧、日药典标准体系与其他标准体系互操作性的比较研究 被引量:1
4
作者 徐昕怡 刘贞 +7 位作者 陶乐然 宋皞昀 李丹 于文力 王冠男 李衡 王芸 杨昭鹏 《中国药师》 CAS 2024年第2期233-241,共9页
目的 为《中国药典》标准体系与外部标准互操作性的优化完善提供参考借鉴。方法 通过检索《中国药典》、美国药典-国家处方集、欧洲药典、日本药典标准与其他标准的引用情况,包括引用本国法规和指导原则、国际标准化组织标准、人用药品... 目的 为《中国药典》标准体系与外部标准互操作性的优化完善提供参考借鉴。方法 通过检索《中国药典》、美国药典-国家处方集、欧洲药典、日本药典标准与其他标准的引用情况,包括引用本国法规和指导原则、国际标准化组织标准、人用药品技术要求国际协调理事会指导原则、世界卫生组织文件、其他国家和国际组织标准等对各药典标准体系的互操作性进行比较。结果 近年来,国际各药典均不断加大对非药典标准的引用。美国药典-国家处方集引用其他标准的种类、数量和领域远超过其他药典。《中国药典》引用其他标准的数量最少。结论 建议《中国药典》在各专业领域的标准中增强与其他标准体系的互操作性,增强《中国药典》的开放性、协调性和先进性,形成更加完善的标准体系。 展开更多
关键词 药典 体系 标准 互操作性 比较
暂未订购
Medicine prescription practices of homeopathic undergraduate students in West Bengal,India
5
作者 Subhranil Saha Munmun Koley +6 位作者 Jogendra Singh Arya Gurudev Choubey Shubhamoy Ghosh Subhasish Ganguly Aloke Ghosh Sangita Saha Malay Mundle 《Journal of Integrative Medicine》 SCIE CAS CSCD 2014年第1期7-12,共6页
OBJECTIVE: To our knowledge, prescription of homeopathic medicines by homeopathic undergraduate students has not been studied before though it may possess serious implications. We aimed to determine the practice and ... OBJECTIVE: To our knowledge, prescription of homeopathic medicines by homeopathic undergraduate students has not been studied before though it may possess serious implications. We aimed to determine the practice and attitudes of prescription by homeopathic undergraduate students. METHODS: A cross-sectional study was carried out involving all the students from four government homeopathic schools of West Bengal, India. Ethical requirements were ensured and data were collected using self-administered questionnaires. Chi-square tests and logistic univariate regression analyses were performed to identify associations and differences. RESULTS: A total of 328 forms were completed. Of these, 264 (80.5%) homeopathic undergraduate students admitted of prescribing medicines independently and most (40.5%) said that they did this 2-3 times a year. The most common reasons for this were 'urgency of the problem' (35.2%), 'previous experience with same kind of illness' (31.8%), and 'the problem too trivial to go to a doctor' (25.8%). About 63.4% of the students thought that it was alright to independently diagnose an illness while 51.2% thought that it was alright for them to prescribe medicines to others. Common conditions encountered were fever, indigestion, and injury. Students who prescribed medicines were more likely to belong to Calcutta Homeopathic Medical College and Hospital (odds ratio = 5.8; 95% confidence interval 2.247-14.972). Prescription by students gradually increased with academic years of homeopathic schools. Many students thought it was alright for students to diagnose and treat illnesses. CONCLUSION: Prescription of medicines by homeopathic undergraduate students is quite rampant and corrective measures are warranted. 展开更多
关键词 HOMEOPATHY education medical undergraduate INDIA prescriptions drug practice institutional drug use irrational
原文传递
各国及地区药典标准体系比较研究 被引量:1
6
作者 徐昕怡 李浩 +3 位作者 凌霄 于文力 李丹 杨昭鹏 《中国食品药品监管》 2024年第9期80-89,共10页
目的:为我国药典标准体系的完善提出合理化建议,增强我国药典标准组成的系统性、内容的先进性、匹配的协调性。方法:以中国、美国、欧洲、日本、英国以及国际药典标准体系为研究对象,综合采用文献法、类型比较法、深度访谈法,对《中国... 目的:为我国药典标准体系的完善提出合理化建议,增强我国药典标准组成的系统性、内容的先进性、匹配的协调性。方法:以中国、美国、欧洲、日本、英国以及国际药典标准体系为研究对象,综合采用文献法、类型比较法、深度访谈法,对《中国药典》《美国药典-国家处方集》《欧洲药典》《日本药局方》《英国药典》《国际药典》的标准体系进行比较和分析。结果:随着科技的飞速发展,以及为加深使用者对监管目标的理解,各国及地区的药典标准体系均在体系架构、新技术标准制定、标准协调等方面不断完善。结论:我国药典标准体系应进一步完善体系架构,明确执行方式,增强与我国药品监管部门发布的指导原则的制定机制和收载内容的一致性和支持性,加强新技术标准的制定和标准的国际协调,加大鼓励企业参与药品标准工作的举措力度。 展开更多
关键词 药典 药品标准 体系 比较
暂未订购
Developing the criteria for evaluating quality of individualization in homeopathic clinical trial reporting:a preliminary study
7
作者 Subhranil Saha Munmun Koley +3 位作者 Subhasish Ganguly Prasanta Rath Pulak Roy Chowdhury Seikh Intaj Hossain 《Journal of Integrative Medicine》 SCIE CAS CSCD 2014年第1期13-19,共7页
OBJECTIVE: This study describes the development of a preliminary version of an instrument that attempts to assess the quality of reports of individualized homeopathic prescriptions in clinical trials and observationa... OBJECTIVE: This study describes the development of a preliminary version of an instrument that attempts to assess the quality of reports of individualized homeopathic prescriptions in clinical trials and observational studies. METHODS: A multidisciplinary panel of 15 judges produced an initial version of the instrument through iterative Delphi rounds and pilot-tested the instrument on five clinical trials. Later they assessed, under blind conditions, the individualization quality of 40 randomly-selected research reports. The final version of the instrument included six criteria. These items were scored consistently by all the raters regardless of background. RESULTS: The instrument appeared to have adequate face and content validity, acceptable internal consistency or reliability (Cronbach's a 0.606 - 0.725), significant discriminant validity (F = 398.7; P 〈 0.000 1), moderate interrater reliability (Fleiss K 0.533), agreeable test-retest reliability (Cohen's K 0.765 - 0.934), moderate sensitivity (0.4; 95% confidence interval 0.253- 0.566), and high specificity (1.0; 95% confidence interval 0.891-1.000). CONCLUSION: The initial data suggest that this instrument may be a promising systematic tool amendable for further development. 展开更多
关键词 clinical trials CONSENSUS Delphi HOMEOPATHY INDIVIDUALIZATION reliability validity
原文传递
中、美、欧、日药典机构和药品监管机构发布的相近内容通用技术要求的比较研究
8
作者 徐昕怡 于文力 +7 位作者 李丹 王冠男 李衡 王芸 刘贞 陶乐然 宋皞昀 杨昭鹏 《中国药学杂志》 CAS CSCD 北大核心 2024年第18期1764-1772,共9页
目的为完善我国药典机构和药品监管机构发布的相近内容指导原则(通用技术要求)的制定机制和收载内容提供参考借鉴。方法通过梳理中国、美国、欧洲、日本药典机构和药品监管机构发布的内容相近的指导原则(通用技术要求),从制定目的、适... 目的为完善我国药典机构和药品监管机构发布的相近内容指导原则(通用技术要求)的制定机制和收载内容提供参考借鉴。方法通过梳理中国、美国、欧洲、日本药典机构和药品监管机构发布的内容相近的指导原则(通用技术要求),从制定目的、适用范围和具体内容的相同点、区别点、相互引用情况进行比较和分析。结果在制剂、生物制品、稳定性、杂质、溶出度、微生物检测、分析方法验证等方面,中、美、欧、日药典机构和药品监管机构存在相近内容的指导原则(通用技术要求),在制定目的和侧重点上有所差异。除我国外,其他国家或地区药典机构和药品监管机构发布的相近内容指导原则(通用技术要求)中重复内容较少,没有相互冲突的内容,两者相互补充,共同支撑药品标准体系。结论建议由我国药品监管机构牵头确定主题,进一步优化完善协调机制,根据各机构的职能,协调、统一药典机构和药品监管机构制定的指导原则(通用技术要求),确保两者在制定目的、适用范围和收载内容上定位清晰。加强两者的互操作性,并与国际标准保持同步。 展开更多
关键词 药典 监管 指导原则 通用技术要求 比较
原文传递
Action of homoeopathic medicines during the interim period of respite produced by artificial morbific agents - a substantialistic approach
9
作者 Sibin Ramabadhran Anandavally Janani Sankar +1 位作者 Lalithambika Kesavakumar Jayasudha Sruthi Krishna 《History & Philosophy of Medicine》 2024年第3期6-8,共3页
Background Various authors have explained Dr.Hahnemann’s concept of vital force and its substantialism.However,the explanation of Dr.Stuart Close,in his book Genius of Homoeopathy,remains in a scientific view.The int... Background Various authors have explained Dr.Hahnemann’s concept of vital force and its substantialism.However,the explanation of Dr.Stuart Close,in his book Genius of Homoeopathy,remains in a scientific view.The introduction of homeopathy involves philosophical and ethical foundations,with Dr.Stuart Close’s work offering a scientific perspective on vital forces and their role in health and disease.His statement,“All force is persistent and indestructible”,is the scientific statement of the Doctrine of Immortality[1].He provided the linear concept of power,force,and motion,representing the physical concepts of our dynamic,vital principle.According to him,power corresponds to a life principle(vital principle),force corresponds to vital force,and motion corresponds to the healthy state of man in the dynamic plane[1].When the life principle is deranged,the vital force becomes improper,leading to disease.Humanity has gone through different periods when it comes to physical well-being to lead a disease-free life.Gone were the times when the human race was expected to endure physical stress due to disease and quick relief is expected nowadays at all levels with the development of innovative and modern medicines.This transient alleviation of symptoms is temporary,and the patient would somehow return with the suffering again.This article emphasizes a new ideology of administering homeopathic medicines during the symptom-free period where the dynamic,vital principle is at rest and the action of which is substituted by yet another artificial morbific agent in materialistic doses,which remains an unavoidable situation that all homeopaths face. 展开更多
关键词 artificial RETURN Action
在线阅读 下载PDF
The theory of pathological simile:unveiling the essence of homoeopathy
10
作者 Sibin Ramabhadran Anandavally Sruthi Krishna +1 位作者 Gopukumar Sivakumar Thangam Nivedha Krishnamoorthy Sajitha Kumari 《History & Philosophy of Medicine》 2024年第1期1-2,共2页
Background Homoeopathy,a therapeutic method based on the principle of‘Similia Similibus Curentur’(like cures like),has been widely practiced and studied since its discovery by Dr.Samuel Hahnemann in the late 18th ce... Background Homoeopathy,a therapeutic method based on the principle of‘Similia Similibus Curentur’(like cures like),has been widely practiced and studied since its discovery by Dr.Samuel Hahnemann in the late 18th century.Over time,numerous homoeopathic stalwarts have contributed to the development and understanding of this system of medicine.Dr.Richard Hughes,a remarkable figure in the field of homoeopathy,has left an indelible mark on the development and understanding of this extraordinary system of medicine. 展开更多
关键词 SIMILE HAS SINCE
在线阅读 下载PDF
Maternal and neonatal outcomes following preterm birth: a retrospective cohort study
11
作者 Vanessa Perez Patel Eric Zuk +4 位作者 Matthew Davis James Li Damien Croft Kara M Rood Hyagriv N Simhan 《Gynecology and Obstetrics Clinical Medicine》 2025年第3期190-199,共10页
Background Preterm births(PTBs)and associated costs in the USA are a public health concern.This study evaluated maternal and neonatal hospital-based outcomes,resource use and costs during delivery and up to 30 days po... Background Preterm births(PTBs)and associated costs in the USA are a public health concern.This study evaluated maternal and neonatal hospital-based outcomes,resource use and costs during delivery and up to 30 days postdischarge following PTB.Methods This study was conducted in the USA among individuals who delivered at≥23 weeks gestation(1 January 2016-30 September 2021)captured in the Premier Al Healthcare Database.Linked neonatal data were used.Regression modelling and sensitivity analyses among spontaneous PTBs were performed.Costs were inflated to US$2022.In-hospital outcomes,resource use and costs were analysed.Results 4303772 deliveries were included;14.8%were linked to neonatal records.Compared with term delivery,adjusted ORs for the<32 and 32 to<37 weeks gestation cohorts,respectively,were 1.33(1.29-1.36)and 0.96(0.95-0.98)for postpartum complications;5.79(5.58-6.01)and 2.73(2.66-2.81)for maternal intensive care unit(ICU)admission;4.20(3.01-5.86)and 1.84(1.38-2.46)for maternal death;1.40(1.37-1.43)and 1.01(1.00-1.02)for maternal readmission;76.92(72.28-81.85)and 5.14(5.03-5.25)for neonatal morbidity;89.58(84.59-94.87)and 10.07(9.84-10.31)for neonatal ICU admission;155.51(130.98184.63)and 8.81(7.24-10.73)for neonatal death and 1.49(1.41-1.58)and 1.16(1.13-1.19)for neonatal readmission.Relative to term births,PTBs had significantly higher per-person maternal and neonatal resource use and costs.The results were robust to sensitivity analyses.Conclusions PTBs present a considerable maternal,neonatal and hospital burden compared with term birth. 展开更多
关键词 preterm birth maternal outcomes retrospective cohort study COSTS hospital resource use sensitivity analyses preterm births ptbs neonatal outcomes
原文传递
Fondaparinux预防老年急性内科患者发生静脉血栓形成的效果与安全性:随机安慰剂对照研究 被引量:6
12
作者 Alexander T Cohen Bruce L Davidson +8 位作者 Alexander S Gallus Michael R Lassen Martin H Prins Witold Tomkowski Alexander G G Turpie Jan F M Egberts Anthonie W A Lensing 石汉平(译) 王深明(校) 《英国医学杂志中文版》 2006年第5期282-285,共4页
目的:观察 Fondaparinux 对具有中高度静脉血栓发生危险的老年急性内科住院患者的抗凝效果与安全性。设计:双盲随机安慰剂对照研究。背景:8个国家的35个中心。参与者:849例≥60岁内科患者,住院原因分别为充血性心力衰竭、慢性肺病合并... 目的:观察 Fondaparinux 对具有中高度静脉血栓发生危险的老年急性内科住院患者的抗凝效果与安全性。设计:双盲随机安慰剂对照研究。背景:8个国家的35个中心。参与者:849例≥60岁内科患者,住院原因分别为充血性心力衰竭、慢性肺病合并急性呼吸系统疾患、急性炎症性或感染性疾病,预期至少住院4天以上。干预:2.5 mg Fondaparinux 或安慰剂,每天1次皮下注射,持续6~14天。观察指标:主要指标为静脉血栓形成(治疗后15天内采用双侧静脉造影检查)及有症状的静脉血栓;次要指标为死亡与出血。患者随访时间为1个月。结果:Fondaparinux 治疗组425例患者和安慰剂组414例患者接受了安全性分析(10例未治疗)。644例患者(75.9%)可接受主要指标分析。静脉血栓检出率在 Fondaparinux 治疗组为5.6%(18/321),安慰剂组为10.5%(34/323),相对危险减少46.7%(95% CI 7.7%~69.3%)。安慰剂组5例患者发生有症状的静脉血栓,Fondaparinux治疗组无患者发生有症状的静脉血栓(P=0.029)。两组均有1例(0.2%)患者发生严重出血。随访结束时,安慰剂组、Fondaparinux 治疗组分别死亡25(6.0%)、14(3.3%)例患者。结论:Fondaparinux 可有效预防急性内科老年患者无症状性及有症状的静脉血栓。严重出血几率两组相似。 展开更多
关键词 安慰剂 血栓 静脉造影 空白剂 血管造影 静脉血栓形成 内科患者 FONDAPARINUX 对照研究 老年
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部